SERPIND1 and rheumatoid arthritis: We have recently demonstrated that MPLA-tDCs derived from HLA-DRB1*0101+ RA patients are capable of efficiently presenting collagen peptide hCII(259–273) to the HLA-DR-restricted T cell hybridoma HCII-9.1 (49).